| Serial Number | 79410014 |
| Word Mark | NEURIZON |
| Filing Date | Monday, October 28, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, October 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Translation of Words in Mark | The wording "NEURIZON" has no meaning in a foreign language |
| Goods and Services | Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development services of new pharmaceutical products; consultancy relating to pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical testing; pharmaceutical product evaluation; providing information about the results of clinical trials for pharmaceuticals; biological, clinical neurological and medical research; consultancy relating to research and development in the field of neurological therapeutics; conducting scientific research in the nature of conducting clinical trials for others; providing information and data for research purposes relating to medical and veterinary research and development; providing information relating to medical research in the field of veterinary pharmacovigilance; veterinary research; veterinary research laboratory services; scientific research for medical purposes in the field of neurological diseases; pharmaceutical drug development services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 21, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurizon Therapeutics Limited |
| Party Type | 12 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | Neurizon Therapeutics Limited |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | PharmAust Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Event Date | Event Description |
| Thursday, November 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 22, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 26, 2025 | ASSIGNED TO EXAMINER |
| Thursday, January 9, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, April 7, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 10, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, June 10, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, April 8, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, June 27, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, July 1, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, June 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 13, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 7, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Tuesday, July 1, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 1, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 1, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 26, 2025 | WITHDRAWN FROM PUB - OG REVIEW QUERY |